International Biotechnology Trust plc Overview
Get informed when a big investor buys or sells
+ Follow40.33%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
International Biotechnology Trust plc (IBT.L) currently reports a ROE of 40.33%. That is above the sector sector average of 11.67%. Use the charts on this page to explore International Biotechnology Trust plc's ROE history and peer comparisons.
International Biotechnology Trust plc's ROE of 40.33% is higher than the its sector sector average of 11.67%. That is roughly 245.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but International Biotechnology Trust plc's current 40.33% should be judged against industry norms (sector average: 11.67%) and against IBT.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 40.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.67%. From there, open related valuation or income-statement pages for International Biotechnology Trust plc, and consider following IBT.L for alerts when major investors trade the stock.
